Commodore Capital

Commodore Capital as of June 30, 2021

Portfolio Holdings for Commodore Capital

Commodore Capital holds 29 positions in its portfolio as reported in the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Aclaris Therapeutics (ACRS) 10.2 $29M 1.7M 17.56
Satsuma Pharmaceuticals Ord 7.6 $22M 3.1M 7.05
Celcuity (CELC) 7.3 $21M 871k 24.00
C4 Therapeutics Com Stk (CCCC) 6.3 $18M 481k 37.84
Cymabay Therapeutics 5.4 $15M 3.5M 4.36
Constellation Pharmceticls I 5.2 $15M 441k 33.80
Cytokinetics Com New (CYTK) 4.9 $14M 704k 19.79
Kura Oncology (KURA) 4.5 $13M 622k 20.85
Cogent Biosciences (COGT) 3.9 $11M 1.4M 8.11
Iveric Bio 3.8 $11M 1.7M 6.31
Celldex Therapeutics Com New (CLDX) 3.8 $11M 323k 33.44
Macrogenics (MGNX) 3.7 $11M 394k 26.86
Vistagen Therapeutics Com New 3.7 $11M 3.3M 3.15
Protagonist Therapeutics (PTGX) 3.3 $9.5M 211k 44.88
Essa Pharma Com New (EPIX) 2.8 $8.1M 282k 28.57
Kronos Bio 2.5 $7.2M 299k 23.95
Genocea Biosciences Com New (GNCAQ) 2.4 $6.9M 2.9M 2.34
Mereo Biopharma Group Ads (MREO) 2.3 $6.5M 2.1M 3.17
Dyne Therapeutics (DYN) 2.2 $6.4M 305k 21.04
Xenon Pharmaceuticals (XENE) 2.1 $6.1M 326k 18.62
Mersana Therapeutics 2.0 $5.8M 429k 13.58
Kalvista Pharmaceuticals (KALV) 1.9 $5.4M 227k 23.96
Pmv Pharmaceuticals (PMVP) 1.5 $4.3M 125k 34.16
Inventiva Sa Ads (IVA) 1.2 $3.6M 263k 13.63
Seres Therapeutics 1.2 $3.5M 146k 23.85
Catabasis Pharmaceuticals In Com New 1.2 $3.4M 1.6M 2.11
Miragen Therapeutics (VRDN) 1.2 $3.4M 186k 18.29
Silverback Therapeutics (SPRY) 1.0 $3.0M 97k 30.89
Bcls Acquisition Corp Com Cl A 0.9 $2.6M 250k 10.53